Richard Löwenthal
Tracked across 1 events · 6 articles · First seen Jun 26, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Richard Löwenthal, CEO of ARS Pharmaceuticals, made several projections about Neffy's formulary coverage that are now under scrutiny as part of the securities investigation.
Jun 26, 2026 · 6 articles
65
Richard Löwenthal misrepresented coverage timelineARS Pharmaceuticals neffy...
60
ARS Pharmaceuticals removed Lowenthal Richard LöwenthalARS Pharmaceuticals neffy...
55
Levi & Korsinsky named as defendants Richard LöwenthalARS Pharmaceuticals neffy...
ERGEN INTELLIGENCE
Track Richard Löwenthal live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard